28
Pankreatitis

PANKREATITIS IPD

Embed Size (px)

DESCRIPTION

hill

Citation preview

Page 1: PANKREATITIS IPD

Pankreatitis

Page 2: PANKREATITIS IPD

Pancreatitis

Definition and Etiology

An inflammation process of the pancreas with associated escape of the pancreatic enzyme into surrounding tissue.

The primary etiologic factors are alcoholism & biliary tract disease.

May be a complication of viral or bacterial disease, peptic ulcer, trauma.

Page 3: PANKREATITIS IPD

Pancreatitis

Incidence & Risk Factors

Major- Biliary stones, Alcohol use/abuseMinor- Age: 55 to 65 yrs. for biliary

pancreatitis 45- 55 yrs. For alcohol-related Female for biliary tract pancreatitis; Male-

for alcohol-related pancreatitis.Trauma, Infectious disease, drug toxicities,

chronic diseases( inflammatory diseases).

Page 4: PANKREATITIS IPD

Table 1. Causes of acute pancreatitis

AlcoholAutoimmuneBiliary (eg, gallstones, gallbladder microlithiasis/sludge)Drug-induced (see Table 2)Iatrogenic

Surgery (eg, common bile duct exploration, sphincterotomy, splenectomy, distal gastrectomy)ERCP

IdiopathicInfectious (eg, ascariasis, clonorchiasis, mumps, toxoplasmosis, coxsackievirus, cytomegalovirus, tuberculosis, Mycobacterium avium complex)Inherited

CFTR (cystic fibrosis transmembrane conductance regulator) mutationsSPINK1 (serine protease inhinitor Kazal type 1) mutationsPRSS1 (cationic trypsinogen) mutations

Metabolic (eg, hypercalcemia, hypertriglyceridemia)Neoplastic (eg, pancreatic or ampullary tumors)Structural (eg, pancreatic divisum, annular pancreas, sphincter of Oddi dysfunction, periampullary diverticula, duodenal duplication cysts, choledochocele, anomalous pancreaticobiliary junction, regional enteritis)Toxic (eg, organophosphates, scorpion venum)Traumatic (especially motor vehicle accidents)Vascular

- in USA, gallstone & alcohol abuse

Page 5: PANKREATITIS IPD

Table 2.Drugs implicated in acute pancreatitis based on class

Class IAa Class IBb Class IIcα-Methyldopa All-transretinoic acid AcetaminophenArabinoside Amiodarone ChlorothiazideAzodisalicylate Azathioprine ClozapineBezafibrate Clomiphene Dideoxyinosine (DDI)Cannabis Dexamethasone ErythromycinCarbimazole Ifosfamide EstrogenCodeine Lamivudine L-AsparaginaseCytosine Losartan PegasparaginaseDapsone Lynesterol/methoxyethinylestradiolPropofolEnalapril 6-mercaptopurine TamoxifenFurosemide MeglumineIsoniazid MethimazoleMesalamine NelfinavirMetronidazole Norethindronate/mestranolPentamidine OmeprazolePravastatin PremarinProcainamide SulfamethoxazolePyritinol Trimethoprim-sulfamethoxazoleSimvastatinStibogluconateSulfamethoxazoleSulindacTetracyclineValproic acid

Page 6: PANKREATITIS IPD

Pancreatitis Ranson’s criteria

Admission criteria Criteria during initial 48 hours

Age: 55 yrs. Or older Hct: decrease or more than 10%

WBC: 16,000/mm3 or higher

BUN:increase greater than 5 mg/dl.

LDH: 350 IU/L or higherGlucose > 200 mg/dl.

CA: falls to less than 8 mg/dl.PaO2 < 60 mm Hg

AST: 250 U/L or higher Fluid sequestration; greater than 6 liter.

Page 7: PANKREATITIS IPD

Table 3. Causes of idiophatic or unexplained acute pancreatitis diagnosed by endoscopic evaluation.*

Ampullary lesionsCholedocholithiasisChronic pancreatitisGallbladder microlithiasis or sludgePancreas divisumPancreatic cancerSphincter of Oddi dysfunction

*Exclusion of hyperlipidemia and medications.

Page 8: PANKREATITIS IPD

Pathogenesis

The latest discovery specifically for hereditary pancreatitis is the discovery of trypsinogen gene mutations: PRSS1 and SPINK1, which leads to impaired balance between proteases and inhibitors in pancreatic parenchyma, causing activation of pancreatic Zymogen with the result of "autodigestion and inflammation". In turn acinar cell damage and improvement of inflammatory cell mediators.

Page 9: PANKREATITIS IPD

Alcohol metabolism and biliary pancreatitis

•The mechanism that is clear, is because alcohol pancreatitis and acute biliary pancreatitis.

•Alcohol metabolism is the process of oxidative and nonoksidatif. Primary oxidative process takes place in the liver, whereas nonoksidatif in the pancreas. Nonoksidatif process will increase the formation of "fatty acid esters ethanol" (FAEEs).

•Biliary pancreatitis caused by the passage of gall bladder stone through the cystic duct into the CBD. Pinched stone in the ampulla Vater will cause reflux of bile into the pancreatic duct or pancreatic duct obstruction exit.

Page 10: PANKREATITIS IPD

Pancreatitis Assessment

Pain:Steady & severe in nature; located in

the epigastric or umbilical region; may radiate to the back. Worsened by lying supine; may be lessened by flexed knee, curved-back position.

VomitingVaries in severity, but is usually protracted, worsened by ingestion of food or fluid. Does not relieve the pain. Usually accompanied by nausea.

Page 11: PANKREATITIS IPD

Pancreatitis Assessment

Fever:Rarely exceeds 39 C.

Abdominal Finding:Rigidity, tenderness, guarding, distended, decreased or absent peristalsis and paralytic ileus.Fatty stools-(steatorrhea)

Laboratory Finding:Elevation of white count- 20,000-50,000.Elevated serum lipase and amylase(5 to 40 times); glucose, bilirubin, alkaline phosphatase. Urine amylase elevated. Abnormal low serum CA, Na & Mg.-due to dehydration. Binding of Ca in areas of fat necrosis.

Page 12: PANKREATITIS IPD

Cullen Sign (periumbilical ecchymoses)

Page 13: PANKREATITIS IPD

Grey Turner’s sign (flank ecchymoses)

Page 15: PANKREATITIS IPD

Idiophatic PancreatitisNegative CT,

negative serology,including lipids and metabolic

panelMRCP, EUS (if

available)CBD stones,pancreatic divisum,

Choledochocele,chronic

pancreatitis with PD stone

Tumor Gallbladder stones/sludge

Autoimmune pancreatitis Normal

Endoscopic therapy Surgery Cholecystectom

yGallbladder in

situ

Gallbladder out

ERCP with sphincter of Oddi manometry,

sphincterotomy if manometry abnormal

Observation

Algorithm for the evaluation & management of idiopathic pancreatitis. CBD: Common Bile DuctCT : Computed TomographyERCP : Endoscopic Retrogade CholangiopancreatographyEUS : Endoscopic UlatrasoundMRCP : Magnetic Resonance CholangiopancreatographyPD : Pancreatic Duct

Page 16: PANKREATITIS IPD

Table 4. Differential diagnosis of acute pancreatitis.Perforated viscusCholecystitisBowel obstructionVascular occlusion (especially mesentery venous disease)Renal colicInferior myocardial infarctionPneumoniaDiabetic ketoacidosisDuodenal ulcer

Page 17: PANKREATITIS IPD

Complication

1. Pancreatic Pseudocyst → Th/ Drainage

2. Abscess formation → Th/ Surgical drainage

3. Pancreatic ascites ∞ from pancreas duct disruption

4. Esophagogastric varices ∞ obstruction of vena lienalis pseudoaneurysm ∞> pseudocyst /

pancreatic necrosis5. Pancreatic Encephalopathy Subcutaneus Fat Necrosis Subcapsular Hematom LimpaRare

Page 18: PANKREATITIS IPD

TherapyA.Mild Acute Pancreatitis

Supportive care • Bowel rest• IV Crystalloid• Analgesia

Pain –Nausea/vomiting –Bising usus +Analgesia –Hungry

Oral intake :Full liquid diet ↓Lowfat solid diet

Gallstone Pancreatitis : Lap-chole orEndoscopic biliarySphincterotomy

Page 19: PANKREATITIS IPD

B. Severe Acute Pancreatitis

Fluid Resuscitation – check Ht every 12 hrsOrgan Failure – ICU

Nasojejunal Tube

Necrotizing Pancreatitis – enzym pankreas PPI AB Surgical debridement / Necrosectomy (3-

4week after medical therapy).

Urgent ERCP (in 24 hrs) for severe acute biliary pancreatitis.

Page 20: PANKREATITIS IPD

Prognostic

Ranson criteriaOn admission

Age > 55 yearsWBC > 16.000/mm3Glucose > 200 mg/dlLactic dehydrogenase > 350 u/lAspartate aminotransferase (SGOT) > 250 u/l

After 48 hours of hospitalizationFall of hematocrit > 10 pointsIncrease of blood urea nitrogen > 2mg/dlSerum calcium < 8mg/dlArterial p O2 < 60 mmHgBase deficit > 5mEq/lFluid sequestration > 6 l

Page 21: PANKREATITIS IPD

Chronic Pankreatitis

Page 22: PANKREATITIS IPD

Table 5. TIGAR-O classification of chronic pancreatitis.

Toxic-MetabolicAlcoholicTobacco smokingHypercalcemia (hyperparathyroidism)Hyperlipidemia (rare and controversial)Chronic renal failure

IdiopathicCause unknown, likely genetic originTropical

GeneticAutosomal dominantCationic trypsinogenAutosomal recessive/modifier genesCFTR mutationsSPINK1 mutationsα₁-Antitrypsin deficiency (possible)

AutoimmuneIsolated autoimmune chronic pancreatitiAssociated with:

• Primary sclerosing cholangitis• Sjögren syndrome• Primary biliary cirrhosis• Type 1 diabetes mellitus

Recurrent and Severe Acute PancreatitisPostnecrotic (severe acute pancreatitis)Vascular diseases/ischemiaPostradiation exposure

ObstructionPancreas divisum (controversial)Sphincter of Oddy dysfunction (controversial)Duct obstruction (tumors, post-traumatic)

Page 23: PANKREATITIS IPD

PathogenesisMorphological changes in chronic pancreatitis occurred in

ductus

Parenchym pankreas

• Dilated• Irregular• Strictured

Glandular tissue→ irregular & patchy→ fibrosis acinar cell

Hypothesis :1. The role of oxidative stress2. Toxic – metabolic causes3. Obstructive causes4. Necrosis – fibrosis (SAPE theory – Sentinel

Acute Pancreatitis Episode)

Page 24: PANKREATITIS IPD

Gambaran Klinis

a. Sign and symptom50% case → * abdominal pain

* pancreatic insufficiency

Page 25: PANKREATITIS IPD

b. Laboratorium1. Amylase & Lipase ↑↑2. Marker of pancreatic exocrine function is fecal pancreatic elastase-1 (FPE1).     Normal: 200 mcg / g of faeces: severe exocrine.pancreatic insufficiency.3. HbA1c4. Marker Autoimmune : IgG4, RhF, ANA

c. Studi Imaging1. BNO 2. USG abdomen3. CT4. MRCP Magnetic Resonance Cholangiopancreatography5. EUS Endoscopic Ulatrasound6. ERCP Endoscopic Retrogade Cholangiopancreatography

Page 26: PANKREATITIS IPD

Diagnosis Differential

Komplikasi

1. Peptic Ulcer2. IBD3. Gastric dysmotility4. IBS

1. Pseudocyst2. Billiary duct obstruction 3. Pancreatic ascites4. Pleural Effesion5. Thrombosis vena lienalis6. Pancreatic Fiastulae7. Pseudoaneurysm8. Risk↑ ca. pancreas

Page 27: PANKREATITIS IPD

Proven Benefit Uncertain Benefit

Smoking cessationAlcohol cessationCoticosteroids for autoimmune pancreatitisAnalgesics

Pancreatic enzyme supplementationTranscranial magnetic brain stimulation

Table 6.Treatment options for chronic pancreatitis

If obstuction : invasive Th/* endoscopic clearance* surgical therapy* ESWL

-Pancreatico jejunostomy-Whipple procedure-Total pancreatectomy

Page 28: PANKREATITIS IPD

References

1. Gastroenterology and . Ed. Gabriele Bianchi Porro. Mc. Graw Hill, 1999 pp. 205 – 233

2. Gastrointestinal System. Second Edition. Ed. Melanie Sarah Long. Mocby, 2002 pp. 103 – 113

3. Gastroenterology, Hepatology & Endoscopy. Ed. Norton J. Greenberger. Matt Large, 2009 pp. 291-309